Analysis of Profitability Ratios
Profitability ratios measure the company ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
Elevance Health Inc., profitability ratios
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Elevance Health Inc. gross profit margin ratio improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Elevance Health Inc. operating profit margin ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Elevance Health Inc. net profit margin ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Elevance Health Inc. ROE deteriorated from 2022 to 2023 and from 2023 to 2024. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Elevance Health Inc. ROA deteriorated from 2022 to 2023 and from 2023 to 2024. |
Gross Profit Margin
Elevance Health Inc., gross profit margin calculation, comparison to benchmarks
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Gross profit | 27,887) | 28,586) | 26,138) | 23,403) | 23,810) | |
| Operating revenue | 175,204) | 170,209) | 155,660) | 136,943) | 120,808) | |
| Profitability Ratio | ||||||
| Gross profit margin1 | 15.92% | 16.79% | 16.79% | 17.09% | 19.71% | |
| Benchmarks | ||||||
| Gross Profit Margin, Competitors2 | ||||||
| Abbott Laboratories | 50.93% | 50.28% | 51.54% | 52.21% | 50.49% | |
| CVS Health Corp. | 13.29% | 14.94% | 16.62% | 17.48% | 18.01% | |
| Intuitive Surgical Inc. | 67.46% | 66.39% | 67.44% | 69.32% | 65.65% | |
| Medtronic PLC | 65.34% | 65.67% | 67.98% | 65.19% | 67.41% | |
| UnitedHealth Group Inc. | 21.31% | 23.64% | 24.09% | 23.60% | 25.62% | |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Gross profit margin = 100 × Gross profit ÷ Operating revenue
= 100 × 27,887 ÷ 175,204 = 15.92%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Elevance Health Inc. gross profit margin ratio improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
Operating Profit Margin
Elevance Health Inc., operating profit margin calculation, comparison to benchmarks
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Operating income | 7,282) | 7,614) | 7,685) | 7,048) | 5,999) | |
| Operating revenue | 175,204) | 170,209) | 155,660) | 136,943) | 120,808) | |
| Profitability Ratio | ||||||
| Operating profit margin1 | 4.16% | 4.47% | 4.94% | 5.15% | 4.97% | |
| Benchmarks | ||||||
| Operating Profit Margin, Competitors2 | ||||||
| Abbott Laboratories | 16.27% | 16.15% | 19.16% | 19.56% | 15.48% | |
| CVS Health Corp. | 2.30% | 3.85% | 2.41% | 4.54% | 5.19% | |
| Intuitive Surgical Inc. | 28.12% | 24.80% | 25.35% | 31.89% | 24.09% | |
| Medtronic PLC | 15.89% | 17.56% | 18.15% | 14.89% | 16.57% | |
| UnitedHealth Group Inc. | 8.17% | 8.80% | 8.83% | 8.40% | 8.76% | |
| Operating Profit Margin, Sector | ||||||
| Health Care Equipment & Services | 6.10% | 6.93% | 6.76% | 7.44% | 7.51% | |
| Operating Profit Margin, Industry | ||||||
| Health Care | 10.05% | 10.60% | 15.03% | 14.99% | 11.62% | |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Operating profit margin = 100 × Operating income ÷ Operating revenue
= 100 × 7,282 ÷ 175,204 = 4.16%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Elevance Health Inc. operating profit margin ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
Net Profit Margin
Elevance Health Inc., net profit margin calculation, comparison to benchmarks
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Shareholders’ net income | 5,980) | 5,987) | 6,025) | 6,104) | 4,572) | |
| Operating revenue | 175,204) | 170,209) | 155,660) | 136,943) | 120,808) | |
| Profitability Ratio | ||||||
| Net profit margin1 | 3.41% | 3.52% | 3.87% | 4.46% | 3.78% | |
| Benchmarks | ||||||
| Net Profit Margin, Competitors2 | ||||||
| Abbott Laboratories | 31.95% | 14.27% | 15.88% | 16.42% | 12.99% | |
| CVS Health Corp. | 1.24% | 2.34% | 1.29% | 2.72% | 2.68% | |
| Intuitive Surgical Inc. | 27.81% | 25.24% | 21.25% | 29.85% | 24.33% | |
| Medtronic PLC | 11.36% | 12.03% | 15.90% | 11.97% | 16.56% | |
| UnitedHealth Group Inc. | 3.65% | 6.09% | 6.25% | 6.06% | 6.03% | |
| Net Profit Margin, Sector | ||||||
| Health Care Equipment & Services | 4.34% | 4.93% | 4.95% | 5.52% | 5.26% | |
| Net Profit Margin, Industry | ||||||
| Health Care | 7.02% | 9.24% | 11.62% | 12.42% | 8.45% | |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Net profit margin = 100 × Shareholders’ net income ÷ Operating revenue
= 100 × 5,980 ÷ 175,204 = 3.41%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Elevance Health Inc. net profit margin ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
Return on Equity (ROE)
Elevance Health Inc., ROE calculation, comparison to benchmarks
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Shareholders’ net income | 5,980) | 5,987) | 6,025) | 6,104) | 4,572) | |
| Shareholders’ equity | 41,315) | 39,306) | 36,307) | 36,060) | 33,199) | |
| Profitability Ratio | ||||||
| ROE1 | 14.47% | 15.23% | 16.59% | 16.93% | 13.77% | |
| Benchmarks | ||||||
| ROE, Competitors2 | ||||||
| Abbott Laboratories | 28.12% | 14.83% | 18.90% | 19.75% | 13.71% | |
| CVS Health Corp. | 6.11% | 10.91% | 5.84% | 10.54% | 10.35% | |
| Intuitive Surgical Inc. | 14.13% | 13.51% | 11.98% | 14.32% | 10.90% | |
| Medtronic PLC | 7.32% | 7.30% | 9.59% | 7.01% | 9.44% | |
| UnitedHealth Group Inc. | 15.55% | 25.22% | 25.87% | 24.09% | 23.52% | |
| ROE, Sector | ||||||
| Health Care Equipment & Services | 13.71% | 15.59% | 15.27% | 15.49% | 14.35% | |
| ROE, Industry | ||||||
| Health Care | 14.75% | 18.50% | 22.94% | 23.78% | 15.95% | |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
ROE = 100 × Shareholders’ net income ÷ Shareholders’ equity
= 100 × 5,980 ÷ 41,315 = 14.47%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Elevance Health Inc. ROE deteriorated from 2022 to 2023 and from 2023 to 2024. |
Return on Assets (ROA)
Elevance Health Inc., ROA calculation, comparison to benchmarks
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Shareholders’ net income | 5,980) | 5,987) | 6,025) | 6,104) | 4,572) | |
| Total assets | 116,889) | 108,928) | 102,772) | 97,460) | 86,615) | |
| Profitability Ratio | ||||||
| ROA1 | 5.12% | 5.50% | 5.86% | 6.26% | 5.28% | |
| Benchmarks | ||||||
| ROA, Competitors2 | ||||||
| Abbott Laboratories | 16.46% | 7.82% | 9.31% | 9.40% | 6.20% | |
| CVS Health Corp. | 1.82% | 3.34% | 1.82% | 3.39% | 3.11% | |
| Intuitive Surgical Inc. | 12.39% | 11.64% | 10.19% | 12.58% | 9.50% | |
| Medtronic PLC | 4.09% | 4.13% | 5.54% | 3.87% | 5.28% | |
| UnitedHealth Group Inc. | 4.83% | 8.18% | 8.19% | 8.15% | 7.81% | |
| ROA, Sector | ||||||
| Health Care Equipment & Services | 5.17% | 5.91% | 5.77% | 6.03% | 5.44% | |
| ROA, Industry | ||||||
| Health Care | 5.25% | 6.71% | 8.71% | 8.70% | 5.45% | |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
ROA = 100 × Shareholders’ net income ÷ Total assets
= 100 × 5,980 ÷ 116,889 = 5.12%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Elevance Health Inc. ROA deteriorated from 2022 to 2023 and from 2023 to 2024. |